KCNK1 | Potassium channel, subfamily K, member 1 | Predicted membrane proteins Voltage-gated ion channels
| | ![](/images/16049/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/16049/38206_A_9_7_rna_selected_60x60.jpg) | Mixed |
KCNK13 | Potassium channel, subfamily K, member 13 | Predicted membrane proteins Voltage-gated ion channels
| ![](/images/3514/ihc_selected_60x60.jpg) | ![](/images/3514/1386_B8_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/3514/11325_B_2_7_rna_selected_60x60.jpg) | Tissue enhanced |
KCNK15 | Potassium channel, subfamily K, member 15 | Predicted membrane proteins Voltage-gated ion channels
| ![](/images/64861/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/64861/144310_B_7_6_rna_selected_60x60.jpg) | Tissue enhanced |
KCNK16 | Potassium channel, subfamily K, member 16 | Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/16567/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16567/37544_B_9_1_rna_selected_60x60.jpg) | Group enriched |
KCNK17 | Potassium channel, subfamily K, member 17 | Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/43892/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43892/102501_B_9_7_rna_selected_60x60.jpg) | Mixed |
KCNK18 | Potassium channel, subfamily K, member 18 | Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images/44739/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44739/97996_B_8_5_rna_selected_60x60.jpg) | Not detected |
KCNK2 | Potassium channel, subfamily K, member 2 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images/56054/ihc_selected_60x60.jpg) | ![](/images/56054/1184_D1_4_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/56054/128419_A_6_4_rna_selected_60x60.jpg) | Tissue enriched |
KCNK3 | Potassium channel, subfamily K, member 3 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/26658/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26658/55343_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
KCNK5 | Potassium channel, subfamily K, member 5 | Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/59148/ihc_selected_60x60.jpg) | ![](/images/59148/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/59148/133677_A_2_8_rna_selected_60x60.jpg) | Mixed |
KCNK6 | Potassium channel, subfamily K, member 6 | Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/40184/ihc_selected_60x60.jpg) | ![](/images/22637/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/22637/48781_A_2_7_rna_selected_60x60.jpg) | Mixed |
KCNK9 | Potassium channel, subfamily K, member 9 | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
KCNMA1 | Potassium large conductance calcium-activated channel, subfamily M, alpha member 1 | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images/57838/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54648/131176_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
KCNN2 | Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/38221/ihc_selected_60x60.jpg) | ![](/images/38221/1368_D7_4_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38221/79370_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
KCNN3 | Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 | Predicted membrane proteins Voltage-gated ion channels
| ![](/images/17990/ihc_selected_60x60.jpg) | ![](/images/57127/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17990/115643_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
KCNN4 | Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters Voltage-gated ion channels
| ![](/images/59622/ihc_selected_60x60.jpg) | ![](/images/53841/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/53841/133784_B_2_4_rna_selected_60x60.jpg) | Tissue enhanced |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48553/123855_A_1_2_rna_selected_60x60.jpg) | Tissue enhanced |
KCNQ2 | Potassium voltage-gated channel, KQT-like subfamily, member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/57112/ihc_selected_60x60.jpg) | ![](/images/57112/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/57112/140451_B_8_1_rna_selected_60x60.jpg) | Group enriched |
KCNQ4 | Potassium voltage-gated channel, KQT-like subfamily, member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/18305/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18305/42288_B_8_2_rna_selected_60x60.jpg) | Mixed |
KCNQ5 | Potassium voltage-gated channel, KQT-like subfamily, member 5 | Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images/16655/ihc_selected_60x60.jpg) | ![](/images/16655/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/16655/38509_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
KCNS2 | Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/51417/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51417/118022_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
KCNS3 | Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 | Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/14864/ihc_selected_60x60.jpg) | ![](/images/14864/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/14864/33788_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
KCNT1 | Potassium channel, subfamily T, member 1 | Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images/59880/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/59880/ihc_cell_selected_60x60.jpg) | ![](/images/59880/139510_B_9_3_rna_selected_60x60.jpg) | Group enriched |
KCNT2 | Potassium channel, subfamily T, member 2 | Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/51218/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/51218/ihc_cell_selected_60x60.jpg) | ![](/images/51218/117029_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
KCNV2 | Potassium channel, subfamily V, member 2 | Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images/31131/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31131/69701_B_7_6_rna_selected_60x60.jpg) | Tissue enriched |
MCOLN1 | Mucolipin 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/31763/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/31763/72216_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
MCOLN2 | Mucolipin 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/19114/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/19114/43843_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
MCOLN3 | Mucolipin 3 | Predicted membrane proteins Voltage-gated ion channels
| ![](/images/62137/ihc_selected_60x60.jpg) | ![](/images/18106/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/62137/145617_B_8_8_rna_selected_60x60.jpg) | Tissue enriched |
PKD2 | Polycystic kidney disease 2 (autosomal dominant) | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/15794/ihc_selected_60x60.jpg) | ![](/images/55297/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/4544/14106_A_9_1_rna_selected_60x60.jpg) | Expressed in all |
PKD2L1 | Polycystic kidney disease 2-like 1 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/22621/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22621/49685_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
PKD2L2 | Polycystic kidney disease 2-like 2 | Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images/41903/ihc_selected_60x60.jpg) | ![](/images/41903/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/41903/90277_B_8_7_rna_selected_60x60.jpg) | Tissue enriched |
SCN11A | Sodium channel, voltage-gated, type XI, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/36746/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36746/78169_A_2_3_rna_selected_60x60.jpg) | Tissue enhanced |
SCN2A | Sodium channel, voltage-gated, type II, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22567/52670_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
SCN3A | Sodium channel, voltage-gated, type III, alpha subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images/35396/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35396/73463_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
SCN4A | Sodium channel, voltage-gated, type IV, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/53992/ihc_selected_60x60.jpg) | ![](/images/53992/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/53992/121967_A_1_4_rna_selected_60x60.jpg) | Group enriched |
SCN9A | Sodium channel, voltage-gated, type IX, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/13679/ihc_selected_60x60.jpg) | ![](/images/61843/1332_D6_4_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/13679/30464_B_9_2_rna_selected_60x60.jpg) | Mixed |
TPCN1 | Two pore segment channel 1 | Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/39757/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39757/88558_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
TPCN2 | Two pore segment channel 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images/16561/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/27080/57948_B_9_8_rna_selected_60x60.jpg) | Expressed in all |
TRPA1 | Transient receptor potential cation channel, subfamily A, member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/26630/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26630/55283_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
TRPC1 | Transient receptor potential cation channel, subfamily C, member 1 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images/21130/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/9387/30894_B_9_2_rna_selected_60x60.jpg) | Mixed |
TRPC3 | Transient receptor potential cation channel, subfamily C, member 3 | Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/37969/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37969/78157_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
TRPC6 | Transient receptor potential cation channel, subfamily C, member 6 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/45098/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45098/103809_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
TRPC7 | Transient receptor potential cation channel, subfamily C, member 7 | Predicted membrane proteins Voltage-gated ion channels
| ![](/images/31126/ihc_selected_60x60.jpg) | ![](/images/31126/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/31126/65262_B_8_6_rna_selected_60x60.jpg) | Not detected |
TRPM1 | Transient receptor potential cation channel, subfamily M, member 1 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images/14785/ihc_selected_60x60.jpg) | ![](/images/14785/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/14785/34060_B_4_5_rna_selected_60x60.jpg) | Group enriched |
TRPM4 | Transient receptor potential cation channel, subfamily M, member 4 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | ![](/images_static/rna_center.gif) | ![](/images/41169/90326_B_9_2_rna_selected_60x60.jpg) | Mixed |
TRPM5 | Transient receptor potential cation channel, subfamily M, member 5 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42115/90698_A_5_3_rna_selected_60x60.jpg) | Group enriched |
TRPM6 | Transient receptor potential cation channel, subfamily M, member 6 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/7037/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7037/19333_B_9_1_rna_selected_60x60.jpg) | Group enriched |
TRPM7 | Transient receptor potential cation channel, subfamily M, member 7 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/35523/ihc_selected_60x60.jpg) | ![](/images/52173/if_selected_60x60.jpg) | ![](/images/35523/147768_A_3_7_selected_60x60.jpg) | ![](/images/35523/73976_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
TRPV4 | Transient receptor potential cation channel, subfamily V, member 4 | Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images/7150/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7150/20710_A_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
TRPV5 | Transient receptor potential cation channel, subfamily V, member 5 | Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/63175/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/63175/151785_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
TRPV6 | Transient receptor potential cation channel, subfamily V, member 6 | Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/62864/140539_A_3_7_selected_60x60.jpg) | ![](/images/62644/1315_E2_3_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/62864/140541_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |